FDA Victory In Civil Money Penalty Case Could Signal More To Come
This article was originally published in The Gray Sheet
Executive Summary
A federal appeals court decision upholding $340,000 in civil money penalties against TMJ Implants for adverse event reporting violations may "embolden" FDA to impose money penalties more often, attorneys familiar with the device industry say